Calcinosis Cutis: Therapeutic Effects of Extracorporeal Shock Wave Therapy (ESWT)

University of Zurich4 enrolled

Overview

Patients with calcinosis cutis due to connective tissue disease get a shock wave therapy. The shock wave therapy will be done in 3 sessions with one week interval. The outcome parameters are: change in pain, size of the calcinosis, of possible ulcers and intake of painkillers. * Trial with medical device

Patients with calcinosis cutis due to connective tissue disease get a shock wave therapy (medical device). The shock wave therapy will be done in 3 sessions with one week interval. The outcome parameters are: change in pain (questionnaire), size of the calcinosis (ultrasound and CT), new ulcers and intake of painkillers.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Calcinosis Cutis in Connective Tissue Disease

Interventions

shock wave therapy with Modulith SLK (Storz)DEVICE

Three sessions with shock wave therapy, interval of one week.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion criteria: * Age of 18 * Calcinosis cutis due to connective tissue disease * information about ESWT given * Patient understands the study and signs the informed consent Exclusion criteria: * No ESWT done * cuagulopathy * sepsis * pregnancy * pace maker * severe disease in the opinion of the investigator * cardiac risk with NYHA III-IV * Ehlers-Danlos-Syndrome

Locations (1)

University Hospital Zurich, Division of Rheumatology

Zurich, Canton of Zurich, Switzerland

Outcomes

Primary Outcomes

change in pain

Time frame: after 6 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.